Clinical Trial Update: A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting results for selexipag in participants who previously took part in a prior selexipag study; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Uptravi (selexipag)

Snippet

Sponsor: Actelion | Conditions: Hypertension, Pulmonary | Phase 3 | Status: COMPLETED | Results posted: 2024-11-20